-
06:24:11 PM

BIOL Stock News

05/26/23 11:25 AM
Nasdaq : BIOL
offering
BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants
BIOLASE, Inc., a global leader in dental lasers, today announced the closing of its previously announced underwritten public offering of 175,000 units, with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable Preferred Stock, par value $0.001 per share, with a liquidation preference of...
RHEA-AI
neutral
05/24/23 9:14 AM
Nasdaq : BIOL
offering
BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants
BIOLASE, Inc., a global leader in dental lasers, today announced the pricing of an underwritten public offering of 175,000 units, with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable Preferred Stock, par value $0.001 per share, with a liquidation preference of $50.00 per share, and one...
RHEA-AI
neutral
05/11/23 4:21 PM
Nasdaq : BIOL
BIOLASE MAINTAINS MOMENTUM AND REPORTS NINTH CONSECUTIVE QUARTER OF YEAR-OVER-YEAR GROWTH; REITERATES FULL YEAR GUIDANCE OF AT LEAST 25% REVENUE GROWTH AND PROFITABILITY FOR FULL YEAR 2023
Reported revenue of $10.5 million, the ninth consecutive quarter of year-over-year growth Increased international laser sales by 22% year over year Record quarter in consumable sales, with U.S. consumable sales increasing 19% year over year, driven by increased procedures using BIOLASE laser systems Generated increased adoption of its...
RHEA-AI
neutral
03/28/23 4:05 PM
Nasdaq : BIOL
BIOLASE DELIVERS 24% REVENUE GROWTH IN 2022 AS GO-TO-MARKET STRATEGIES GAIN MOMENTUM; GUIDES FOR AT LEAST 25% REVENUE GROWTH AND PROFITABILITY IN 2023
BIOLASE, Inc., the global leader in dental lasers, today announced its financial results for the fourth quarter and full year ended December 31, 2022. Achieved year-over-year revenue growth of 24% to $48.5 million Increased U.S. laser sales by 39% year over year Achieved record U.S. consumable sales, up 25% year over year, driven by increased procedures using...
RHEA-AI
neutral
03/14/23 6:30 AM
Nasdaq : BIOL
BIOLASE GATHERS KEY OPINION LEADERS AND DENTAL CLINICIANS TO HIGHLIGHT TONGUE-TIE TREATMENT BEST PRACTICES
BIOLASE, Inc., the global leader in dental lasers, today announced plans to host its annual Tequila& Tongue Ties conference, a gathering of key opinion leaders and dental clinicians to further educate the medical community on tethered oral tissues, including lip-ties and tongue-ties in infants and children, which affects a significant number of newborns.
RHEA-AI
positive